Table of Contents 1 Colloids (Blood Plasma) Market Overview 1.1 Product Overview and Scope of Colloids (Blood Plasma) 1.2 Colloids (Blood Plasma) Segment by Type 1.2.1 Global Colloids (Blood Plasma) Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Natural Type Colloids (Blood Plasma) 1.2.3 Synthetic Type Colloids (Blood Plasma) 1.3 Colloids (Blood Plasma) Segment by Application 1.3.1 Colloids (Blood Plasma) Sales Comparison by Application: 2020 VS 2026 1.3.2 Extensive Burns 1.3.3 Massive Blood or Plasma Loss 1.3.4 Hypovolemic Shock 1.3.5 Others 1.4 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts 1.4.1 Global Colloids (Blood Plasma) Revenue 2015-2026 1.4.2 Global Colloids (Blood Plasma) Sales 2015-2026 1.4.3 Colloids (Blood Plasma) Market Size by Region: 2020 Versus 2026 2 Global Colloids (Blood Plasma) Market Competition by Manufacturers 2.1 Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2015-2020) 2.2 Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2015-2020) 2.3 Global Colloids (Blood Plasma) Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Colloids (Blood Plasma) Manufacturing Sites, Area Served, Product Type 2.5 Colloids (Blood Plasma) Market Competitive Situation and Trends 2.5.1 Colloids (Blood Plasma) Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Colloids (Blood Plasma) Players (Opinion Leaders) 3 Colloids (Blood Plasma) Retrospective Market Scenario by Region 3.1 Global Colloids (Blood Plasma) Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Colloids (Blood Plasma) Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Colloids (Blood Plasma) Market Facts & Figures by Country 3.3.1 North America Colloids (Blood Plasma) Sales by Country 3.3.2 North America Colloids (Blood Plasma) Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Colloids (Blood Plasma) Market Facts & Figures by Country 3.4.1 Europe Colloids (Blood Plasma) Sales by Country 3.4.2 Europe Colloids (Blood Plasma) Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Colloids (Blood Plasma) Market Facts & Figures by Region 3.5.1 Asia Pacific Colloids (Blood Plasma) Sales by Region 3.5.2 Asia Pacific Colloids (Blood Plasma) Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Colloids (Blood Plasma) Market Facts & Figures by Country 3.6.1 Latin America Colloids (Blood Plasma) Sales by Country 3.6.2 Latin America Colloids (Blood Plasma) Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country 3.7.1 Middle East and Africa Colloids (Blood Plasma) Sales by Country 3.7.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Colloids (Blood Plasma) Historic Market Analysis by Type 4.1 Global Colloids (Blood Plasma) Sales Market Share by Type (2015-2020) 4.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2015-2020) 4.3 Global Colloids (Blood Plasma) Price Market Share by Type (2015-2020) 4.4 Global Colloids (Blood Plasma) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Colloids (Blood Plasma) Historic Market Analysis by Application 5.1 Global Colloids (Blood Plasma) Sales Market Share by Application (2015-2020) 5.2 Global Colloids (Blood Plasma) Revenue Market Share by Application (2015-2020) 5.3 Global Colloids (Blood Plasma) Price by Application (2015-2020) 6 Company Profiles and Key Figures in Colloids (Blood Plasma) Business 6.1 CSL Behring 6.1.1 Corporation Information 6.1.2 CSL Behring Description, Business Overview and Total Revenue 6.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.1.4 CSL Behring Products Offered 6.1.5 CSL Behring Recent Development 6.2 Baxter 6.2.1 Baxter Colloids (Blood Plasma) Production Sites and Area Served 6.2.2 Baxter Description, Business Overview and Total Revenue 6.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Baxter Products Offered 6.2.5 Baxter Recent Development 6.3 Grifols 6.3.1 Grifols Colloids (Blood Plasma) Production Sites and Area Served 6.3.2 Grifols Description, Business Overview and Total Revenue 6.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Grifols Products Offered 6.3.5 Grifols Recent Development 6.4 Octapharma 6.4.1 Octapharma Colloids (Blood Plasma) Production Sites and Area Served 6.4.2 Octapharma Description, Business Overview and Total Revenue 6.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Octapharma Products Offered 6.4.5 Octapharma Recent Development 6.5 Kedrion 6.5.1 Kedrion Colloids (Blood Plasma) Production Sites and Area Served 6.5.2 Kedrion Description, Business Overview and Total Revenue 6.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Kedrion Products Offered 6.5.5 Kedrion Recent Development 6.6 Shanghai Raas 6.6.1 Shanghai Raas Colloids (Blood Plasma) Production Sites and Area Served 6.6.2 Shanghai Raas Description, Business Overview and Total Revenue 6.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Shanghai Raas Products Offered 6.6.5 Shanghai Raas Recent Development 6.7 CTBB 6.6.1 CTBB Colloids (Blood Plasma) Production Sites and Area Served 6.6.2 CTBB Description, Business Overview and Total Revenue 6.6.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 CTBB Products Offered 6.7.5 CTBB Recent Development 6.8 Hualan Bio 6.8.1 Hualan Bio Colloids (Blood Plasma) Production Sites and Area Served 6.8.2 Hualan Bio Description, Business Overview and Total Revenue 6.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Hualan Bio Products Offered 6.8.5 Hualan Bio Recent Development 6.9 Rongsheng Pharmaceutical 6.9.1 Rongsheng Pharmaceutical Colloids (Blood Plasma) Production Sites and Area Served 6.9.2 Rongsheng Pharmaceutical Description, Business Overview and Total Revenue 6.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Rongsheng Pharmaceutical Products Offered 6.9.5 Rongsheng Pharmaceutical Recent Development 6.10 Boya Rongsheng 6.10.1 Boya Rongsheng Colloids (Blood Plasma) Production Sites and Area Served 6.10.2 Boya Rongsheng Description, Business Overview and Total Revenue 6.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Boya Rongsheng Products Offered 6.10.5 Boya Rongsheng Recent Development 6.11 B. Braun Medical 6.11.1 B. Braun Medical Colloids (Blood Plasma) Production Sites and Area Served 6.11.2 B. Braun Medical Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.11.4 B. Braun Medical Products Offered 6.11.5 B. Braun Medical Recent Development 6.12 Fresenius Kabi 6.12.1 Fresenius Kabi Colloids (Blood Plasma) Production Sites and Area Served 6.12.2 Fresenius Kabi Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Fresenius Kabi Products Offered 6.12.5 Fresenius Kabi Recent Development 6.13 HOSPIRA 6.13.1 HOSPIRA Colloids (Blood Plasma) Production Sites and Area Served 6.13.2 HOSPIRA Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.13.4 HOSPIRA Products Offered 6.13.5 HOSPIRA Recent Development 6.14 Axa parenterals 6.14.1 Axa parenterals Colloids (Blood Plasma) Production Sites and Area Served 6.14.2 Axa parenterals Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Axa parenterals Products Offered 6.14.5 Axa parenterals Recent Development 6.15 Fresenius Kabi(China) 6.15.1 Fresenius Kabi(China) Colloids (Blood Plasma) Production Sites and Area Served 6.15.2 Fresenius Kabi(China) Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.15.3 Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Fresenius Kabi(China) Products Offered 6.15.5 Fresenius Kabi(China) Recent Development 6.16 CR Double-Crane 6.16.1 CR Double-Crane Colloids (Blood Plasma) Production Sites and Area Served 6.16.2 CR Double-Crane Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.16.4 CR Double-Crane Products Offered 6.16.5 CR Double-Crane Recent Development 6.17 Kelun Group 6.17.1 Kelun Group Colloids (Blood Plasma) Production Sites and Area Served 6.17.2 Kelun Group Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.17.4 Kelun Group Products Offered 6.17.5 Kelun Group Recent Development 6.18 Shandong Qidu Pharmaceutical 6.18.1 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Production Sites and Area Served 6.18.2 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.18.4 Shandong Qidu Pharmaceutical Products Offered 6.18.5 Shandong Qidu Pharmaceutical Recent Development 6.19 Shandong Hualu Pharmaceutical 6.19.1 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Production Sites and Area Served 6.19.2 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.19.4 Shandong Hualu Pharmaceutical Products Offered 6.19.5 Shandong Hualu Pharmaceutical Recent Development 6.20 Minsheng Pharma 6.20.1 Minsheng Pharma Colloids (Blood Plasma) Production Sites and Area Served 6.20.2 Minsheng Pharma Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.20.4 Minsheng Pharma Products Offered 6.20.5 Minsheng Pharma Recent Development 6.21 Kanglepharm 6.21.1 Kanglepharm Colloids (Blood Plasma) Production Sites and Area Served 6.21.2 Kanglepharm Colloids (Blood Plasma) Description, Business Overview and Total Revenue 6.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020) 6.21.4 Kanglepharm Products Offered 6.21.5 Kanglepharm Recent Development 7 Colloids (Blood Plasma) Manufacturing Cost Analysis 7.1 Colloids (Blood Plasma) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Colloids (Blood Plasma) 7.4 Colloids (Blood Plasma) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Colloids (Blood Plasma) Distributors List 8.3 Colloids (Blood Plasma) Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Colloids (Blood Plasma) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Colloids (Blood Plasma) by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Colloids (Blood Plasma) by Type (2021-2026) 10.2 Colloids (Blood Plasma) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Colloids (Blood Plasma) by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Colloids (Blood Plasma) by Application (2021-2026) 10.3 Colloids (Blood Plasma) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Colloids (Blood Plasma) by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Colloids (Blood Plasma) by Region (2021-2026) 10.4 North America Colloids (Blood Plasma) Estimates and Projections (2021-2026) 10.5 Europe Colloids (Blood Plasma) Estimates and Projections (2021-2026) 10.6 Asia Pacific Colloids (Blood Plasma) Estimates and Projections (2021-2026) 10.7 Latin America Colloids (Blood Plasma) Estimates and Projections (2021-2026) 10.8 Middle East and Africa Colloids (Blood Plasma) Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Colloids (Blood Plasma) Sales (MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Colloids (Blood Plasma) Sales (MT) Comparison by Application: 2020 VS 2026 Table 3. Global Colloids (Blood Plasma) Market Size by Type (MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Colloids (Blood Plasma) Manufacturers Covered in This Study Table 5. Global Colloids (Blood Plasma) Sales (MT) by Manufacturers (2015-2020) Table 6. Global Colloids (Blood Plasma) Sales Share by Manufacturers (2015-2020) Table 7. Global Colloids (Blood Plasma) Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Colloids (Blood Plasma) Average Price (USD/Kg) of Key Manufacturers (2015-2020) Table 10. Manufacturers Colloids (Blood Plasma) Sales Sites and Area Served Table 11. Manufacturers Colloids (Blood Plasma) Product Types Table 12. Global Colloids (Blood Plasma) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colloids (Blood Plasma) as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Colloids (Blood Plasma) Players Table 16. Global Colloids (Blood Plasma) Sales (MT) by Region (2015-2020) Table 17. Global Colloids (Blood Plasma) Sales Market Share by Region (2015-2020) Table 18. Global Colloids (Blood Plasma) Revenue (Million US$) by Region (2015-2020) Table 19. Global Colloids (Blood Plasma) Revenue Market Share by Region (2015-2020) Table 20. North America Colloids (Blood Plasma) Sales by Country (2015-2020) (MT) Table 21. North America Colloids (Blood Plasma) Sales Market Share by Country (2015-2020) Table 22. North America Colloids (Blood Plasma) Revenue by Country (2015-2020) (US$ Million) Table 23. North America Colloids (Blood Plasma) Revenue Market Share by Country (2015-2020) Table 24. Europe Colloids (Blood Plasma) Sales by Country (2015-2020) (MT) Table 25. Europe Colloids (Blood Plasma) Sales Market Share by Country (2015-2020) Table 26. Europe Colloids (Blood Plasma) Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Colloids (Blood Plasma) Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Colloids (Blood Plasma) Sales by Region (2015-2020) (MT) Table 29. Asia Pacific Colloids (Blood Plasma) Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Colloids (Blood Plasma) Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Colloids (Blood Plasma) Revenue Market Share by Region (2015-2020) Table 32. Latin America Colloids (Blood Plasma) Sales by Country (2015-2020) (MT) Table 33. Latin America Colloids (Blood Plasma) Sales Market Share by Country (2015-2020) Table 34. Latin America Colloids (Blood Plasma) Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Colloids (Blood Plasma) Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2015-2020) (MT) Table 37. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Colloids (Blood Plasma) Revenue Market Share by Country (2015-2020) Table 40. Global Colloids (Blood Plasma) Sales (MT) by Type (2015-2020) Table 41. Global Colloids (Blood Plasma) Sales Share by Type (2015-2020) Table 42. Global Colloids (Blood Plasma) Revenue (Million US$) by Type (2015-2020) Table 43. Global Colloids (Blood Plasma) Revenue Share by Type (2015-2020) Table 44. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2015-2020) Table 45. Global Colloids (Blood Plasma) Sales (MT) by Application (2015-2020) Table 46. Global Colloids (Blood Plasma) Sales Market Share by Application (2015-2020) Table 47. Global Colloids (Blood Plasma) Sales Growth Rate by Application (2015-2020) Table 48. CSL Behring Colloids (Blood Plasma) Corporation Information Table 49. CSL Behring Description and Business Overview Table 50. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 51. CSL Behring Main Product Table 52. CSL Behring Recent Development Table 53. Baxter Colloids (Blood Plasma) Corporation Information Table 54. Baxter Corporation Information Table 55. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 56. Baxter Main Product Table 57. Baxter Recent Development Table 58. Grifols Colloids (Blood Plasma) Corporation Information Table 59. Grifols Corporation Information Table 60. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 61. Grifols Main Product Table 62. Grifols Recent Development Table 63. Octapharma Colloids (Blood Plasma) Corporation Information Table 64. Octapharma Corporation Information Table 65. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 66. Octapharma Main Product Table 67. Octapharma Recent Development Table 68. Kedrion Colloids (Blood Plasma) Corporation Information Table 69. Kedrion Corporation Information Table 70. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 71. Kedrion Main Product Table 72. Kedrion Recent Development Table 73. Shanghai Raas Colloids (Blood Plasma) Corporation Information Table 74. Shanghai Raas Corporation Information Table 75. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 76. Shanghai Raas Main Product Table 77. Shanghai Raas Recent Development Table 78. CTBB Colloids (Blood Plasma) Corporation Information Table 79. CTBB Corporation Information Table 80. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 81. CTBB Main Product Table 82. CTBB Recent Development Table 83. Hualan Bio Colloids (Blood Plasma) Corporation Information Table 84. Hualan Bio Corporation Information Table 85. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 86. Hualan Bio Main Product Table 87. Hualan Bio Recent Development Table 88. Rongsheng Pharmaceutical Colloids (Blood Plasma) Corporation Information Table 89. Rongsheng Pharmaceutical Corporation Information Table 90. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 91. Rongsheng Pharmaceutical Main Product Table 92. Rongsheng Pharmaceutical Recent Development Table 93. Boya Rongsheng Colloids (Blood Plasma) Corporation Information Table 94. Boya Rongsheng Corporation Information Table 95. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 96. Boya Rongsheng Main Product Table 97. Boya Rongsheng Recent Development Table 98. B. Braun Medical Colloids (Blood Plasma) Corporation Information Table 99. B. Braun Medical Corporation Information Table 100. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 101. B. Braun Medical Main Product Table 102. B. Braun Medical Recent Development Table 103. Fresenius Kabi Colloids (Blood Plasma) Corporation Information Table 104. Fresenius Kabi Corporation Information Table 105. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 106. Fresenius Kabi Main Product Table 107. Fresenius Kabi Recent Development Table 108. HOSPIRA Colloids (Blood Plasma) Corporation Information Table 109. HOSPIRA Corporation Information Table 110. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 111. HOSPIRA Main Product Table 112. HOSPIRA Recent Development Table 113. Axa parenterals Colloids (Blood Plasma) Corporation Information Table 114. Axa parenterals Corporation Information Table 115. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 116. Axa parenterals Main Product Table 117. Axa parenterals Recent Development Table 118. Fresenius Kabi(China) Colloids (Blood Plasma) Corporation Information Table 119. Fresenius Kabi(China) Corporation Information Table 120. Fresenius Kabi(China) Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 121. Fresenius Kabi(China) Main Product Table 122. Fresenius Kabi(China) Recent Development Table 123. CR Double-Crane Colloids (Blood Plasma) Corporation Information Table 124. CR Double-Crane Corporation Information Table 125. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 126. CR Double-Crane Main Product Table 127. CR Double-Crane Recent Development Table 128. Kelun Group Colloids (Blood Plasma) Corporation Information Table 129. Kelun Group Corporation Information Table 130. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 131. Kelun Group Main Product Table 132. Kelun Group Recent Development Table 133. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Corporation Information Table 134. Shandong Qidu Pharmaceutical Corporation Information Table 135. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 136. Shandong Qidu Pharmaceutical Main Product Table 137. Shandong Qidu Pharmaceutical Recent Development Table 138. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Corporation Information Table 139. Shandong Hualu Pharmaceutical Corporation Information Table 140. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 141. Shandong Hualu Pharmaceutical Main Product Table 142. Shandong Hualu Pharmaceutical Recent Development Table 143. Minsheng Pharma Colloids (Blood Plasma) Corporation Information Table 144. Minsheng Pharma Corporation Information Table 145. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 146. Minsheng Pharma Main Product Table 147. Minsheng Pharma Recent Development Table 148. Kanglepharm Colloids (Blood Plasma) Corporation Information Table 149. Kanglepharm Corporation Information Table 150. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 151. Kanglepharm Main Product Table 152. Kanglepharm Recent Development Table 153. Sales Base and Market Concentration Rate of Raw Material Table 154. Key Suppliers of Raw Materials Table 155. Colloids (Blood Plasma) Distributors List Table 156. Colloids (Blood Plasma) Customers List Table 157. Market Key Trends Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 159. Key Challenges Table 160. Global Colloids (Blood Plasma) Sales (MT) Forecast by Type (2021-2026) Table 161. Global Colloids (Blood Plasma) Sales Market Share Forecast by Type (2021-2026) Table 162. Global Colloids (Blood Plasma) Revenue (Million US$) Forecast by Type (2021-2026) Table 163. Global Colloids (Blood Plasma) Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 164. Global Colloids (Blood Plasma) Sales (MT) Forecast by Application (2021-2026) Table 165. Global Colloids (Blood Plasma) Revenue (Million US$) Forecast by Application (2021-2026) Table 166. Global Colloids (Blood Plasma) Sales (MT) Forecast by Region (2021-2026) Table 167. Global Colloids (Blood Plasma) Sales Market Share Forecast by Region (2021-2026) Table 168. Global Colloids (Blood Plasma) Revenue Forecast by Region (2021-2026) (US$ Million) Table 169. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Region (2021-2026) Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Colloids (Blood Plasma) Figure 2. Global Colloids (Blood Plasma) Sales Market Share by Type: 2020 VS 2026 Figure 3. Natural Type Colloids (Blood Plasma) Product Picture Figure 4. Synthetic Type Colloids (Blood Plasma) Product Picture Figure 5. Global Colloids (Blood Plasma) Consumption Market Share by Application: 2020 VS 2026 Figure 6. Extensive Burns Figure 7. Massive Blood or Plasma Loss Figure 8. Hypovolemic Shock Figure 9. Others Figure 10. Global Colloids (Blood Plasma) Market Size 2015-2026 (US$ Million) Figure 11. Global Colloids (Blood Plasma) Sales Capacity (MT) (2015-2026) Figure 12. Global Colloids (Blood Plasma) Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Colloids (Blood Plasma) Sales Share by Manufacturers in 2020 Figure 14. Global Colloids (Blood Plasma) Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Colloids (Blood Plasma) Revenue in 2019 Figure 16. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Colloids (Blood Plasma) Sales Market Share by Region (2015-2020) Figure 18. Global Colloids (Blood Plasma) Sales Market Share by Region in 2019 Figure 19. Global Colloids (Blood Plasma) Revenue Market Share by Region (2015-2020) Figure 20. Global Colloids (Blood Plasma) Revenue Market Share by Region in 2019 Figure 21. North America Colloids (Blood Plasma) Sales Market Share by Country in 2019 Figure 22. North America Colloids (Blood Plasma) Revenue Market Share by Country in 2019 Figure 23. U.S. Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 24. U.S. Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 26. Canada Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Colloids (Blood Plasma) Sales Market Share by Country in 2019 Figure 28. Europe Colloids (Blood Plasma) Revenue Market Share by Country in 2019 Figure 29. Germany Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 30. Germany Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 32. France Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 34. U.K. Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 36. Italy Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 38. Russia Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Colloids (Blood Plasma) Sales Market Share by Region in 2019 Figure 40. Asia Pacific Colloids (Blood Plasma) Revenue Market Share by Region in 2019 Figure 41. China Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 42. China Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 44. Japan Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 46. South Korea Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 48. India Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 50. Australia Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 52. Taiwan Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 54. Indonesia Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 56. Thailand Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 58. Malaysia Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 60. Philippines Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 62. Vietnam Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Colloids (Blood Plasma) Sales Market Share by Country in 2019 Figure 64. Latin America Colloids (Blood Plasma) Revenue Market Share by Country in 2019 Figure 65. Mexico Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 66. Mexico Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 68. Brazil Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 70. Argentina Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Colloids (Blood Plasma) Revenue Market Share by Country in 2019 Figure 73. Turkey Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 74. Turkey Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 76. Saudi Arabia Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Colloids (Blood Plasma) Sales Growth Rate (2015-2020) (MT) Figure 78. U.A.E Colloids (Blood Plasma) Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Colloids (Blood Plasma) by Type (2015-2020) Figure 80. Sales Market Share of Colloids (Blood Plasma) by Type in 2019 Figure 81. Revenue Share of Colloids (Blood Plasma) by Type (2015-2020) Figure 82. Revenue Market Share of Colloids (Blood Plasma) by Type in 2019 Figure 83. Global Colloids (Blood Plasma) Sales Growth by Type (2015-2020) (MT) Figure 84. Global Colloids (Blood Plasma) Sales Market Share by Application (2015-2020) Figure 85. Global Colloids (Blood Plasma) Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Colloids (Blood Plasma) by Application (2015-2020) Figure 87. Global Revenue Share of Colloids (Blood Plasma) by Application in 2020 Figure 88. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Grifols Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Shanghai Raas Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. CTBB Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Rongsheng Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Boya Rongsheng Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. B. Braun Medical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. HOSPIRA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Axa parenterals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Fresenius Kabi(China) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. CR Double-Crane Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Kelun Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Shandong Qidu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Shandong Hualu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Minsheng Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 108. Kanglepharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Price Trend of Key Raw Materials Figure 110. Manufacturing Cost Structure of Colloids (Blood Plasma) Figure 111. Manufacturing Process Analysis of Colloids (Blood Plasma) Figure 112. Colloids (Blood Plasma) Industrial Chain Analysis Figure 113. Channels of Distribution Figure 114. Distributors Profiles Figure 115. Porter's Five Forces Analysis Figure 116. North America Colloids (Blood Plasma) Sales (MT) and Growth Rate Forecast (2021-2026) Figure 117. North America Colloids (Blood Plasma) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Europe Colloids (Blood Plasma) Sales (MT) and Growth Rate Forecast (2021-2026) Figure 119. Europe Colloids (Blood Plasma) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Latin America Colloids (Blood Plasma) Sales (MT) and Growth Rate Forecast (2021-2026) Figure 121. Latin America Colloids (Blood Plasma) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Middle East and Africa Colloids (Blood Plasma) Sales (MT) and Growth Rate Forecast (2021-2026) Figure 123. Middle East and Africa Colloids (Blood Plasma) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Asia Pacific Colloids (Blood Plasma) Sales (MT) and Growth Rate Forecast (2021-2026) Figure 125. Asia Pacific Colloids (Blood Plasma) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 126. Bottom-up and Top-down Approaches for This Report Figure 127. Data Triangulation Figure 128. Key Executives Interviewed

CSL Behring Baxter Grifols Octapharma Kedrion Shanghai Raas CTBB Hualan Bio Rongsheng Pharmaceutical Boya Rongsheng B. Braun Medical Fresenius Kabi HOSPIRA Axa parenterals Fresenius Kabi(China) CR Double-Crane Kelun Group Shandong Qidu Pharmaceutical Shandong Hualu Pharmaceutical Minsheng Pharma Kanglepharm